Is Scribe Therapeutics Inc. overvalued?

Scribe Therapeutics Inc. (SCTX) — key valuation metrics and fundamentals.

No verdict

Price

$29.74

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$481.3M

Dividend yield

0.0%

Return on equity

—

Sector

Healthcare

Fair value compares SCTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 9 Sep 2026.

Related stocks